Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Intradialytic Exercise, Symptoms, and Well-being in Hemodialysis Patients

12. november 2026 opdateret af: Muş Alparslan University

The Effects of Intradialytic Aerobic Exercise on Dialysis-Related Symptoms and Well-being in Haemodialysis Patients: A Randomized Controlled Trial

**Study Summary**

Hemodialysis patients frequently experience a high burden of dialysis-related symptoms, including fatigue, muscle weakness, pain, sleep disturbances, pruritus, and psychological complaints. These symptoms may negatively affect daily functioning and overall well-being. Intradialytic exercise has been proposed as a feasible complementary intervention to improve health-related outcomes in this population, as it allows patients to engage in physical activity during their routine hemodialysis sessions.

This study aims to investigate the effects of intradialytic aerobic exercise on dialysis-related symptoms and subjective well-being in patients undergoing maintenance hemodialysis. A randomized controlled trial will be conducted involving patients receiving regular hemodialysis treatment. Participants will be randomly allocated to either an intervention group or a control group. The intervention group will perform intradialytic aerobic exercise using a pedal exercise device during hemodialysis sessions, while the control group will continue to receive standard hemodialysis care without an additional exercise intervention.

The intervention will be implemented over a six-week period, with exercise sessions conducted three times per week. Dialysis-related symptoms will be assessed using the Dialysis Symptom Index (DSI), while subjective well-being will be evaluated using the World Health Organization-Five Well-Being Index (WHO-5). Both outcome measures will be administered before and after the intervention.

The primary objective is to determine whether intradialytic aerobic exercise reduces dialysis-related symptom burden compared with standard care. The secondary objective is to evaluate its effects on subjective well-being. The findings are expected to provide further evidence regarding the potential role of intradialytic aerobic exercise as a practical intervention for improving patient-centered outcomes in individuals receiving maintenance hemodialysis.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

50

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Undersøgelse Kontakt Backup

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 80 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Having received hemodialysis treatment for 4 hours a day, 3 days a week, for at least 3 months.

Exclusion Criteria:

  • Having a history of myocardial infarction within the last 3 months
  • Having angina pectoris or uncontrolled arrhythmia and uncontrolled hypertension
  • Having communication or cognitive problems to the extent that one cannot complete the required tests
  • Being pregnant or undergoing infertility treatment
  • Having a psychiatric diagnosis

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: aerobic exercise

Participants assigned to this group will perform intradialytic aerobic exercise using a pedal ergometer while lying in a supine position during hemodialysis sessions. Exercise will be performed using the lower extremities for 20 minutes per session at a moderate intensity corresponding to 12-16 on the Borg Rating of Perceived Exertion Scale. The intervention will be conducted three times per week for 6 weeks during routine hemodialysis treatment. Participants will continue to receive standard hemodialysis care throughout the intervention.

The use of intradialytic aerobic exercise in hemodialysis patients.

Ingen indgriben: control group

Participants assigned to the control group will receive routine hemodialysis treatment without any additional exercise intervention throughout the 6-week study period. No pedal ergometer exercise or other structured physical activity program will be provided as part of the study.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Dialysis Symptom Index (DSI)
Tidsramme: Baseline and 6 weeks.

Dialysis-related symptom burden will be assessed using the Dialysis Symptom Index (DSI), a 30-item instrument evaluating the presence and severity of physical and emotional symptoms experienced by hemodialysis patients. Higher total scores indicate a greater symptom burden. The change in DSI total score from baseline to the end of the 6-week intervention will be compared between the intervention and control groups.

Baseline and 6 weeks.

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
World Health Organization-Five Well-Being Index (WHO-5)
Tidsramme: Baseline and 6 weeks.

Subjective well-being will be assessed using the World Health Organization-Five Well-Being Index (WHO-5), a 5-item self-report questionnaire evaluating subjective psychological well-being over the previous two weeks. Total scores range from 0 to 100, with higher scores indicating better well-being. The change in WHO-5 total score from baseline to the end of the 6-week intervention will be compared between the intervention and control groups.

Baseline and 6 weeks.

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Studieleder: Cengiz TAŞKAYA, Muş Alparslan University

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

30. november 2026

Primær færdiggørelse (Anslået)

4. januar 2027

Studieafslutning (Anslået)

22. januar 2027

Datoer for studieregistrering

Først indsendt

12. november 2026

Først indsendt, der opfyldte QC-kriterier

12. november 2026

Først opslået (Faktiske)

18. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

12. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner